Levodopa-Loaded 3D-Printed Poly (Lactic) Acid/Chitosan Neural Tissue Scaffold as a Promising Drug Delivery System for the Treatment of Parkinson’s Disease
Parkinson’s disease, the second most common neurodegenerative disease in the world, develops due to decreased dopamine levels in the basal ganglia. Levodopa, a dopamine precursor used in the treatment of Parkinson’s disease, can be used as a drug delivery system. This study presents an approach to t...
Guardado en:
Autores principales: | Ezgi Saylam, Yigit Akkaya, Elif Ilhan, Sumeyye Cesur, Ece Guler, Ali Sahin, Muhammmet Emin Cam, Nazmi Ekren, Faik Nuzhet Oktar, Oguzhan Gunduz, Denisa Ficai, Anton Ficai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5a32de00877d4bf1bcf76f834ab8d9b3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Levodopa en la enfermedad de Parkinson: ¿Qué hemos aprendido?
por: Juri C,Carlos, et al.
Publicado: (2006) -
Magnetite-Silica Core/Shell Nanostructures: From Surface Functionalization towards Biomedical Applications—A Review
por: Angela Spoială, et al.
Publicado: (2021) -
Electrocatalytic determination of levodopa in presence of cabergoline using carbon paste electrode modified with graphene quantum dots/2-chlorobenzoyl ferrocene/ionic liquid
por: Peyman Mohammadzadeh Jahani
Publicado: (2021) -
Consideraciones sobre las complicaciones motoras y neurotoxicidad de la levodopa en la enfermedad de Parkinson
por: Venegas F.,Pablo
Publicado: (2005) -
Bioactive Glass—An Extensive Study of the Preparation and Coating Methods
por: Maxim Maximov, et al.
Publicado: (2021)